Mark A. Damante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mark A. Damante has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- James Bradley Elder
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA
8 shared publications - Guilherme Finger
Department of Neurological Surgery, Indiana University, Indianapolis, Indiana
5 shared publications J. Bradley Elder
5 shared publicationsKyle C. Wu
Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, USA
4 shared publicationsRussell R. Lonser
4 shared publicationsDaniel Kreatsoulas
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, USA
3 shared publications
Latest Publications
- 21 November 2026
- Published by Elsevier in Molecular Therapy
Direct convective delivery for gene therapy targeting central nervous system disorders
- 21 November 2026
- Published by Elsevier in Molecular Therapy
Direct convective delivery for gene therapy targeting central nervous system disorders
- Open Access
Chemically modified CRISPR enzymes for multi-organ genome editing in vivo
Delivery remains the main obstacle to the development of in vivo genome editing therapies. CRISPR ribonucleoproteins confer high editing activity with transient exposure but lack intrinsic cell entry and targeting. Here we introduce PERCEPT, a delivery platform featuring reversible, covalent modification of CRISPR enzymes. PERCEPT enables modular installation of shielding polymers, amphiphilic delivery peptides and targeting ligands, allowing traceless cytosolic release of the native editor. A formulation incorporating an amphiphilic delivery peptide and the neuron-targeting ligand TET1 edited approximately 56% of striatal volume and 78% of neurons within edited regions after local striatal administration. In the R6/2 Huntington's disease model, PERCEPT mediated targeted editing of the mutant human HTT transgene, reducing mutant huntingtin aggregate burden and shifting local transcriptional programs away from inflammatory and injury-associated states. Tissue-adapted formulations edited 53% of Muller glia following intravitreal delivery, increased skeletal muscle reporter fluorescence tenfold versus unconjugated control following intramuscular injection, and enabled lung airway epithelial cell that persisted for three months following intranasal delivery. Rapid screening revealed that local anatomical and cellular barriers require distinct surface display for optimal editing. These results establish reversible chemical modification as a general strategy for adapting CRISPR enzyme delivery across multiple target tissues in vivo.
Open AccessChemically modified CRISPR enzymes for multi-organ genome editing in vivo
Delivery remains the main obstacle to the development of in vivo genome editing therapies. CRISPR ribonucleoproteins confer high editing activity with transient exposure but lack intrinsic cell entry and targeting. Here we introduce PERCEPT, a delivery platform featuring reversible, covalent modification of CRISPR enzymes. PERCEPT enables modular installation of shielding polymers, amphiphilic delivery peptides and targeting ligands, allowing traceless cytosolic release of the native editor. A formulation incorporating an amphiphilic delivery peptide and the neuron-targeting ligand TET1 edited approximately 56% of striatal volume and 78% of neurons within edited regions after local striatal administration. In the R6/2 Huntington's disease model, PERCEPT mediated targeted editing of the mutant human HTT transgene, reducing mutant huntingtin aggregate burden and shifting local transcriptional programs away from inflammatory and injury-associated states. Tissue-adapted formulations edited 53% of Muller glia following intravitreal delivery, increased skeletal muscle reporter fluorescence tenfold versus unconjugated control following intramuscular injection, and enabled lung airway epithelial cell that persisted for three months following intranasal delivery. Rapid screening revealed that local anatomical and cellular barriers require distinct surface display for optimal editing. These results establish reversible chemical modification as a general strategy for adapting CRISPR enzyme delivery across multiple target tissues in vivo.
- Open Access
- 17 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12  (7)
Technical nuances of endoscopic transcortical transventricular fenestration for management of giant suprasellar arachnoid cysts in adults: illustrative cases
BACKGROUND: Arachnoid cysts (ACs) are collections of CSF within an arachnoid membrane. Suprasellar ACs (SACs) constitute 1%–9% of all ACs, with giant SACs representing a rarer subset at increased risk of rupture, intracranial hemorrhage, and neurological deficits. While ventriculostomy is well characterized, anatomical considerations and technical nuances of cystocisternostomy remain limited; adult presentation and outcomes remain poorly defined. The authors describe surgical technique and postoperative outcomes in 2 adult patients undergoing endoscopic ventriculocystocisternostomy for giant SACs. OBSERVATIONS: Both cases were managed with endoscopic transventricular ventriculocisternostomy. Intraoperatively, an absent tuber cinereum allowed for cyst wall fenestration under direct visualization. The first case was a 33-year-old male with bitemporal hemianopsia, headaches, and memory loss. He experienced significant improvement in his bitemporal hemianopsia and resolution of headaches at 1 year. The second case was a 36-year-old female with debilitating daily headaches, which decreased to one or two episodes per week at 5 months postoperatively. Follow-up imaging demonstrated decreased cyst size and mass effect. LESSONS: Giant ACs warrant closer surveillance and often surgery due to higher risks of deficits. Careful anatomical orientation and controlled dual fenestration are key to achieving durable decompression. Endoscopic ventriculocisternostomy is a feasible and effective approach for symptomatic SACs. https://thejns.org/doi/10.3171/CASE26372
- 17 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12  (7)
Open AccessTechnical nuances of endoscopic transcortical transventricular fenestration for management of giant suprasellar arachnoid cysts in adults: illustrative cases
BACKGROUND: Arachnoid cysts (ACs) are collections of CSF within an arachnoid membrane. Suprasellar ACs (SACs) constitute 1%–9% of all ACs, with giant SACs representing a rarer subset at increased risk of rupture, intracranial hemorrhage, and neurological deficits. While ventriculostomy is well characterized, anatomical considerations and technical nuances of cystocisternostomy remain limited; adult presentation and outcomes remain poorly defined. The authors describe surgical technique and postoperative outcomes in 2 adult patients undergoing endoscopic ventriculocystocisternostomy for giant SACs. OBSERVATIONS: Both cases were managed with endoscopic transventricular ventriculocisternostomy. Intraoperatively, an absent tuber cinereum allowed for cyst wall fenestration under direct visualization. The first case was a 33-year-old male with bitemporal hemianopsia, headaches, and memory loss. He experienced significant improvement in his bitemporal hemianopsia and resolution of headaches at 1 year. The second case was a 36-year-old female with debilitating daily headaches, which decreased to one or two episodes per week at 5 months postoperatively. Follow-up imaging demonstrated decreased cyst size and mass effect. LESSONS: Giant ACs warrant closer surveillance and often surgery due to higher risks of deficits. Careful anatomical orientation and controlled dual fenestration are key to achieving durable decompression. Endoscopic ventriculocisternostomy is a feasible and effective approach for symptomatic SACs. https://thejns.org/doi/10.3171/CASE26372
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Postoperative Motor Trajectories and Their Impact on Survival After Resection of Motor Region Metastases
BACKGROUND AND OBJECTIVES: Surgical resection of brain metastases involving motor regions can preserve neurological function while improving oncological control. However, predictors of motor outcomes after surgery and their survival implications remain incompletely defined. This study evaluated preoperative clinical and radiographic features associated with motor deficits at presentation and aimed to correlate them with postoperative motor outcome trajectories and overall survival after resection. METHODS: A retrospective cohort study of patients with resected brain metastases involving motor regions was performed. Motor function was assessed immediately pre- and post-operatively, at 30 days, and followed for up to 90 days. Multivariable logistic and multinomial regression identified predictors of preoperative and postoperative motor outcomes. Cox proportional hazards model was used to determine the impact of these variables on 12-month survival. RESULTS: Sixty patients with motor metastases were included. Preoperative motor deficits were common (74.2% arm; 43.9% leg). Improvement or resolution was observed in 50.0% of arm and 27.3% of leg deficits. New postoperative motor deficits of the arm or leg occurred in 16.7% of cases. 50% of new postoperative deficits recovered to baseline by 30 days. Higher preoperative performance status was independently associated with reduced odds of adverse motor outcomes, particularly for the upper extremity (odds ratio [OR] 0.87, P = .02). Tumor hemorrhage was associated with reduced likelihood of postoperative motor improvement (OR 18.33, P = .01) but not increased risk of deterioration (OR 5.12, P = .22). Persistent (hazard ratio [HR] 11.12, P = .04) or worsened (HR 14.7, P = .02) postoperative arm deficits, but not leg deficits, were associated with decreased overall survival. Hemorrhagic lesions also independently predicted worse survival (HR 3.95, P = .02). CONCLUSION: Resection of motor metastases is associated with favorable neurological outcomes in most patients. Preoperative functional status and postoperative upper-extremity motor recovery were key determinants of survival, underscoring the importance of neurological preservation in surgical decision-making and patient counseling.
- 21 July 2026
- Published by Wolters Kluwer Health in Neurosurgery
Postoperative Motor Trajectories and Their Impact on Survival After Resection of Motor Region Metastases
BACKGROUND AND OBJECTIVES: Surgical resection of brain metastases involving motor regions can preserve neurological function while improving oncological control. However, predictors of motor outcomes after surgery and their survival implications remain incompletely defined. This study evaluated preoperative clinical and radiographic features associated with motor deficits at presentation and aimed to correlate them with postoperative motor outcome trajectories and overall survival after resection. METHODS: A retrospective cohort study of patients with resected brain metastases involving motor regions was performed. Motor function was assessed immediately pre- and post-operatively, at 30 days, and followed for up to 90 days. Multivariable logistic and multinomial regression identified predictors of preoperative and postoperative motor outcomes. Cox proportional hazards model was used to determine the impact of these variables on 12-month survival. RESULTS: Sixty patients with motor metastases were included. Preoperative motor deficits were common (74.2% arm; 43.9% leg). Improvement or resolution was observed in 50.0% of arm and 27.3% of leg deficits. New postoperative motor deficits of the arm or leg occurred in 16.7% of cases. 50% of new postoperative deficits recovered to baseline by 30 days. Higher preoperative performance status was independently associated with reduced odds of adverse motor outcomes, particularly for the upper extremity (odds ratio [OR] 0.87, P = .02). Tumor hemorrhage was associated with reduced likelihood of postoperative motor improvement (OR 18.33, P = .01) but not increased risk of deterioration (OR 5.12, P = .22). Persistent (hazard ratio [HR] 11.12, P = .04) or worsened (HR 14.7, P = .02) postoperative arm deficits, but not leg deficits, were associated with decreased overall survival. Hemorrhagic lesions also independently predicted worse survival (HR 3.95, P = .02). CONCLUSION: Resection of motor metastases is associated with favorable neurological outcomes in most patients. Preoperative functional status and postoperative upper-extremity motor recovery were key determinants of survival, underscoring the importance of neurological preservation in surgical decision-making and patient counseling.
- 3 June 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Prescriptive Approach to Convective Perfusion of the Bilateral Thalami for Gene Therapy
BACKGROUND AND OBJECTIVES: Consistent and effective convective perfusion of the thalamus for gene therapy across surgeons and institutions will be critical for therapeutic success. To determine if a systematic infusion approach can ensure reliable and successful delivery across surgeons and centers, we developed and used a systematic perfusion technique with real-time imaging to deliver gene therapy to the bilateral thalami. METHODS: Consecutive subjects with frontotemporal dementia undergoing convective infusion of adeno-associated virus serotype 9 expressing the granulin gene (coinfused with 1 mM gadolinium) into bilateral thalami at 3 sites internationally were included. Subjects underwent perfusion (infusion rate, 1-15 μL/min) of the anterior and posterior thalami [volume of infusion (Vi), 1200 or 1600 μL per thalamus] using a standardized perfusion protocol. Infusions were monitored using real-time MRI. Clinical and imaging findings were analyzed. RESULTS: Six consecutive subjects (mean age, 58.5 ± 6.2 years) received systematic bilateral anterior and posterior thalamic infusions (mean follow-up, 10.4 ± 8.5 months). The mean trajectory length from the rostral to caudal border of the thalamus was 16.9 ± 1.6 mm (range, 14-21 mm). The mean total volume of distribution (Vd) per thalamus was 3.2 ± 0.2 and 4.2 ± 0.6 cm 3 (Vi, 1200 and 1600). Real-time MRI demonstrated that Vd increased linearly with increasing Vi (R 2 = 0.96). Overall, the mean Vd to Vi ratio was 2.7 ± 0.4 (range, 2.4-3.5). The mean thalamic coverage was 48.7% ± 2.3% and 52.6% ± 6.8% (Vi, 1200 and 1600). Systematic use of the cannula position and increasing infusion rate achieved consistent effective intrathalamic distribution (mean within thalamus perfusion, 72.7% ± 8.3%). CONCLUSION: Systematic convective delivery to the thalamus ensures consistent perfusion and enhances both accessibility and procedural uniformity across surgeons and institutions. This methodology reduces the learning curve for convective perfusion and will permit practitioners to implement the technique more efficiently and effectively.
- 3 June 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Prescriptive Approach to Convective Perfusion of the Bilateral Thalami for Gene Therapy
BACKGROUND AND OBJECTIVES: Consistent and effective convective perfusion of the thalamus for gene therapy across surgeons and institutions will be critical for therapeutic success. To determine if a systematic infusion approach can ensure reliable and successful delivery across surgeons and centers, we developed and used a systematic perfusion technique with real-time imaging to deliver gene therapy to the bilateral thalami. METHODS: Consecutive subjects with frontotemporal dementia undergoing convective infusion of adeno-associated virus serotype 9 expressing the granulin gene (coinfused with 1 mM gadolinium) into bilateral thalami at 3 sites internationally were included. Subjects underwent perfusion (infusion rate, 1-15 μL/min) of the anterior and posterior thalami [volume of infusion (Vi), 1200 or 1600 μL per thalamus] using a standardized perfusion protocol. Infusions were monitored using real-time MRI. Clinical and imaging findings were analyzed. RESULTS: Six consecutive subjects (mean age, 58.5 ± 6.2 years) received systematic bilateral anterior and posterior thalamic infusions (mean follow-up, 10.4 ± 8.5 months). The mean trajectory length from the rostral to caudal border of the thalamus was 16.9 ± 1.6 mm (range, 14-21 mm). The mean total volume of distribution (Vd) per thalamus was 3.2 ± 0.2 and 4.2 ± 0.6 cm 3 (Vi, 1200 and 1600). Real-time MRI demonstrated that Vd increased linearly with increasing Vi (R 2 = 0.96). Overall, the mean Vd to Vi ratio was 2.7 ± 0.4 (range, 2.4-3.5). The mean thalamic coverage was 48.7% ± 2.3% and 52.6% ± 6.8% (Vi, 1200 and 1600). Systematic use of the cannula position and increasing infusion rate achieved consistent effective intrathalamic distribution (mean within thalamus perfusion, 72.7% ± 8.3%). CONCLUSION: Systematic convective delivery to the thalamus ensures consistent perfusion and enhances both accessibility and procedural uniformity across surgeons and institutions. This methodology reduces the learning curve for convective perfusion and will permit practitioners to implement the technique more efficiently and effectively.
- 20 April 2026
- Published by Elsevier in Neurosurgery Clinics of North America
- Vol. 37  (3) , 401-409
Hemangioblastomas of the Spinal Cord
- 20 April 2026
- Published by Elsevier in Neurosurgery Clinics of North America
- Vol. 37  (3) , 401-409
Hemangioblastomas of the Spinal Cord
- 18 February 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Robot-Assisted Placement of Convection-Enhanced Delivery Infusion Cannulas
BACKGROUND AND OBJECTIVES: Indications for convective delivery of putative therapeutics are rapidly expanding. Cerebellar targets, such as the dentate nucleus, will be crucial to target in certain conditions. Current skull-mounted, magnetic resonance (MR) imaging–compatible platforms preclude infratentorial approach to cerebellar targets. We assessed the feasibility, effectiveness, and accuracy of computed tomography (CT) and MR imaging guided, robot-assisted placement of convection enhanced delivery (CED) cannulas. METHODS: Cadaveric (n = 5) specimens underwent preoperative CT and MR-imaging for trajectory and target (bilateral dentate nuclei) planning followed by robot-assisted placement of suboccipital cannulas (n = 10). Placement accuracy was assessed using CT and MR-imaging. RESULTS: All cadaveric (3 female, 2 male) specimens underwent successful suboccipital placement of bilateral CED cannulas to the dentate nuclei along defined trajectories. Mean incision to cannula placement time was 22 ± 0.6 minutes (range, 13-35 minutes). Medial-lateral error was 1.2 ± 1.1 mm (range, 0.1-3.6 mm), rostral-caudal error was 1.0 ± 0.6 mm (range, 0.1-2.1 mm), and depth error was 0.7 ± 0.4 mm (range, 0.2-1.5 mm) on CT. Mean medial-lateral error was 1.4 ± 0.9 mm (range, 0.1-2.8 mm), rostral-caudal error was 0.9 ± 0.5 mm (range, 0.3-1.8 mm), and depth error was 0.9 ± 0.6 mm (range, 0.1-2.0 mm) on MR imaging. CT accuracy errors were analogous to MR imaging errors ( t -test, P ≥ .3). CONCLUSION: Image-guided, robot-assisted placement of CED cannulas is feasible, accurate, and efficient. This paradigm can provide advantages in placing convective infusion cannulas compared with existing methods.
- 18 February 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Robot-Assisted Placement of Convection-Enhanced Delivery Infusion Cannulas
BACKGROUND AND OBJECTIVES: Indications for convective delivery of putative therapeutics are rapidly expanding. Cerebellar targets, such as the dentate nucleus, will be crucial to target in certain conditions. Current skull-mounted, magnetic resonance (MR) imaging–compatible platforms preclude infratentorial approach to cerebellar targets. We assessed the feasibility, effectiveness, and accuracy of computed tomography (CT) and MR imaging guided, robot-assisted placement of convection enhanced delivery (CED) cannulas. METHODS: Cadaveric (n = 5) specimens underwent preoperative CT and MR-imaging for trajectory and target (bilateral dentate nuclei) planning followed by robot-assisted placement of suboccipital cannulas (n = 10). Placement accuracy was assessed using CT and MR-imaging. RESULTS: All cadaveric (3 female, 2 male) specimens underwent successful suboccipital placement of bilateral CED cannulas to the dentate nuclei along defined trajectories. Mean incision to cannula placement time was 22 ± 0.6 minutes (range, 13-35 minutes). Medial-lateral error was 1.2 ± 1.1 mm (range, 0.1-3.6 mm), rostral-caudal error was 1.0 ± 0.6 mm (range, 0.1-2.1 mm), and depth error was 0.7 ± 0.4 mm (range, 0.2-1.5 mm) on CT. Mean medial-lateral error was 1.4 ± 0.9 mm (range, 0.1-2.8 mm), rostral-caudal error was 0.9 ± 0.5 mm (range, 0.3-1.8 mm), and depth error was 0.9 ± 0.6 mm (range, 0.1-2.0 mm) on MR imaging. CT accuracy errors were analogous to MR imaging errors ( t -test, P ≥ .3). CONCLUSION: Image-guided, robot-assisted placement of CED cannulas is feasible, accurate, and efficient. This paradigm can provide advantages in placing convective infusion cannulas compared with existing methods.
- 12 December 2025
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 176  (1) , 120
Management of intermediate-sized brain metastases of the primary motor cortex
- 12 December 2025
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 176  (1) , 120
Management of intermediate-sized brain metastases of the primary motor cortex
- 1 May 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 58  (5) , E10
Durability of carbon fiber–reinforced PEEK spinal instrumentation in spine oncology: a single-institution longitudinal experience
OBJECTIVE: Carbon fiber–reinforced polyetheretherketone (CFR-PEEK) instrumentation is increasingly being used in patients with spine tumors as the body of literature supporting its benefit in local disease surveillance and radiation planning grows. Small single-institution experiences with short-term follow-up have yet to demonstrate issues with construct durability despite different biomechanical properties of CFR-PEEK compared to titanium. In this study the authors evaluated CFR-PEEK hardware failures in patients with surgically treated spine tumors who had long-term follow-up. METHODS: This is an IRB-approved retrospective cohort study of patients with spine tumors who underwent instrumented spinal fusion with CFR-PEEK or titanium instrumentation at a single tertiary care center. Inclusion criteria were as follows: 1) age > 18 years; 2) pedicle screw fixation with CFR-PEEK or titanium; and 3) minimum 6 months of follow-up. The surgical indication was reviewed and agreed upon at a multidisciplinary spine tumor board meeting. RESULTS: A total of 190 patients undergoing CFR-PEEK instrumentation were identified during the study period; 148 had at least a 6-month follow-up. Of those 148, the median follow-up was 13.7 months. In total, there were 861 CFR-PEEK pedicle screws, 266 CFR-PEEK spinal rods, and 15 CFR-PEEK corpectomy cages included in the study. Percutaneous CFR-PEEK instrumentation was performed in 13 cases. There were 6 (4.1%) CFR-PEEK cases of mechanical/hardware failure, with a median interval time to failure of 5.51 (range 2.74–9.38) months. There were no hardware-related complications in the 26 patients who received CFR-PEEK instrumentation and who had a > 24-month follow-up. CONCLUSIONS: This institutional experience provides the largest cohort with long-term follow-up to evaluate CFR-PEEK–related instrumentation failure in patients with spine tumors. The rate of hardware failure among CFR-PEEK instrumented constructs was comparable to that in the current literature for titanium implants used in degenerative spine and spine oncology treatment. Importantly, there were no hardware failures noted among patients with extended long-term survival, reinforcing the durability of CFR-PEEK instrumentation.
- 1 May 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 58  (5) , E10
Durability of carbon fiber–reinforced PEEK spinal instrumentation in spine oncology: a single-institution longitudinal experience
OBJECTIVE: Carbon fiber–reinforced polyetheretherketone (CFR-PEEK) instrumentation is increasingly being used in patients with spine tumors as the body of literature supporting its benefit in local disease surveillance and radiation planning grows. Small single-institution experiences with short-term follow-up have yet to demonstrate issues with construct durability despite different biomechanical properties of CFR-PEEK compared to titanium. In this study the authors evaluated CFR-PEEK hardware failures in patients with surgically treated spine tumors who had long-term follow-up. METHODS: This is an IRB-approved retrospective cohort study of patients with spine tumors who underwent instrumented spinal fusion with CFR-PEEK or titanium instrumentation at a single tertiary care center. Inclusion criteria were as follows: 1) age > 18 years; 2) pedicle screw fixation with CFR-PEEK or titanium; and 3) minimum 6 months of follow-up. The surgical indication was reviewed and agreed upon at a multidisciplinary spine tumor board meeting. RESULTS: A total of 190 patients undergoing CFR-PEEK instrumentation were identified during the study period; 148 had at least a 6-month follow-up. Of those 148, the median follow-up was 13.7 months. In total, there were 861 CFR-PEEK pedicle screws, 266 CFR-PEEK spinal rods, and 15 CFR-PEEK corpectomy cages included in the study. Percutaneous CFR-PEEK instrumentation was performed in 13 cases. There were 6 (4.1%) CFR-PEEK cases of mechanical/hardware failure, with a median interval time to failure of 5.51 (range 2.74–9.38) months. There were no hardware-related complications in the 26 patients who received CFR-PEEK instrumentation and who had a > 24-month follow-up. CONCLUSIONS: This institutional experience provides the largest cohort with long-term follow-up to evaluate CFR-PEEK–related instrumentation failure in patients with spine tumors. The rate of hardware failure among CFR-PEEK instrumented constructs was comparable to that in the current literature for titanium implants used in degenerative spine and spine oncology treatment. Importantly, there were no hardware failures noted among patients with extended long-term survival, reinforcing the durability of CFR-PEEK instrumentation.
- 21 February 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97  (2) , 448-455
Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study
BACKGROUND AND OBJECTIVE: Maximal safe resection of newly diagnosed glioblastoma (GBM) optimizes clinical outcomes. For patients who receive biopsy or subtotal resection (STR), early repeat resection (ERR) to improve extent of resection can be considered but is controversial. Oncological outcomes of patients undergoing ERR for residual GBM to patients receiving upfront at least near-total resection were compared. METHODS: This case-control study including patients with GBM treated at a single institution identified 3 treatment groups: (1) ERR patients underwent biopsy or STR (P -value of <.05 was considered significant. RESULTS: A total of 22 ERR patients (16 biopsies and 6 STR) were identified, and each was matched with a control patient. Baseline patient characteristics at presentation did not differ between matched patients. Time from first surgery to chemoradiation was longer in the ERR cohort (1.8 vs 1.1 months, P < .001). Median overall survival (mOS) (17.7 vs 20.3 months, P = .87) and progression-free survival (5.5 vs 4.5 months, P = .25) did not differ between ERR and control groups, respectively. In the biopsy-only group, mOS was 4.1. Univariate Cox-regression analysis suggested age, failure to complete chemoradiation, isocitrate dehydrogenase-wt, and hemorrhage at presentation were independent predictors of mOS, whereas only age and failure to complete chemoradiation remained independent predictors of mOS after multivariate analysis. Surgical complications were similar between cohorts. CONCLUSION: ERR achieving ≥95% extent of resection within 8 weeks of initial surgery results in similar oncological outcomes to upfront ≥NTR in a case-control–matched analysis despite delayed initiation in chemoradiation for the ERR cohort.
- 21 February 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97  (2) , 448-455
Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study
BACKGROUND AND OBJECTIVE: Maximal safe resection of newly diagnosed glioblastoma (GBM) optimizes clinical outcomes. For patients who receive biopsy or subtotal resection (STR), early repeat resection (ERR) to improve extent of resection can be considered but is controversial. Oncological outcomes of patients undergoing ERR for residual GBM to patients receiving upfront at least near-total resection were compared. METHODS: This case-control study including patients with GBM treated at a single institution identified 3 treatment groups: (1) ERR patients underwent biopsy or STR (P -value of <.05 was considered significant. RESULTS: A total of 22 ERR patients (16 biopsies and 6 STR) were identified, and each was matched with a control patient. Baseline patient characteristics at presentation did not differ between matched patients. Time from first surgery to chemoradiation was longer in the ERR cohort (1.8 vs 1.1 months, P < .001). Median overall survival (mOS) (17.7 vs 20.3 months, P = .87) and progression-free survival (5.5 vs 4.5 months, P = .25) did not differ between ERR and control groups, respectively. In the biopsy-only group, mOS was 4.1. Univariate Cox-regression analysis suggested age, failure to complete chemoradiation, isocitrate dehydrogenase-wt, and hemorrhage at presentation were independent predictors of mOS, whereas only age and failure to complete chemoradiation remained independent predictors of mOS after multivariate analysis. Surgical complications were similar between cohorts. CONCLUSION: ERR achieving ≥95% extent of resection within 8 weeks of initial surgery results in similar oncological outcomes to upfront ≥NTR in a case-control–matched analysis despite delayed initiation in chemoradiation for the ERR cohort.